Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker AURA
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jun 16, 2026 | Anthony S. Gibney See Remarks | AURA Aura Biosciences, Inc. | Sale | 12,824 | $6.42 | $82.3K Sale | Form 4 ↗ |
| May 7, 2026 | Matrix Capital Management Company, LP 10% owner | AURA Aura Biosciences, Inc. | Sale | 6.92M | $5.64 | $39.0M Sale | Form 4 ↗ |
| Apr 16, 2026 | Conor Kilroy See Remarks | AURA Aura Biosciences, Inc. | Sale | 11,738 | $7.02 | $82.4K Sale | Form 4 ↗ |
| Feb 17, 2026 | Conor Kilroy See Remarks | AURA Aura Biosciences, Inc. | Sale | 12,079 | $5.05 | $61.0K Sale | Form 4 ↗ |
| Feb 17, 2026 | Mark Plavsic Chief Technology Officer | AURA Aura Biosciences, Inc. | Sale | 15,890 | $5.05 | $80.2K Sale | Form 4 ↗ |
| Feb 17, 2026 | Janet Jill Hopkins Chief Medical Officer | AURA Aura Biosciences, Inc. | Sale | 20,401 | $5.06 | $103.2K Sale | Form 4 ↗ |
| Feb 17, 2026 | Amy Elazzouzi Senior Vice President, Finance | AURA Aura Biosciences, Inc. | Sale | 8,549 | $5.06 | $43.3K Sale | Form 4 ↗ |
| Feb 17, 2026 | Pinos Elisabet de los See Remarks, Director | AURA Aura Biosciences, Inc. | Sale | 47,648 | $5.06 | $241.1K Sale | Form 4 ↗ |
| Jan 20, 2026 | Amy Elazzouzi Senior Vice President, Finance | AURA Aura Biosciences, Inc. | Sale | 1,581 | $4.86 | $7,684 Sale | Form 4 ↗ |
| Jan 20, 2026 | Pinos Elisabet de los See Remarks, Director | AURA Aura Biosciences, Inc. | Sale | 16,928 | $4.86 | $82.3K Sale | Form 4 ↗ |
| Nov 17, 2025 | Janet Jill Hopkins Chief Medical Officer | AURA Aura Biosciences, Inc. | Sale | 17,109 | $5.42 | $92.7K Sale | Form 4 ↗ |
| Oct 29, 2025 | Amy Elazzouzi Senior Vice President, Finance | AURA Aura Biosciences, Inc. | Sale | 896 | $6.35 | $5,690 Sale | Form 4 ↗ |
| Oct 29, 2025 | Pinos Elisabet de los See Remarks, Director | AURA Aura Biosciences, Inc. | Sale | 9,049 | $6.35 | $57.5K Sale | Form 4 ↗ |
| Oct 16, 2025 | Mark Plavsic Chief Technology Officer | AURA Aura Biosciences, Inc. | Sale | 12,169 | $6.35 | $77.3K Sale | Form 4 ↗ |
| Aug 18, 2025 | Amy Elazzouzi Senior Vice President, Finance | AURA Aura Biosciences, Inc. | Sale | 7,722 | $6.70 | $51.7K Sale | Form 4 ↗ |
| May 16, 2025 | David Michael Johnson Director | AURA Aura Biosciences, Inc. | Buy | 20,000 | $4.90 | $98.0K Buy | Form 4 ↗ |
| May 16, 2025 | Anthony S. Gibney See Remarks | AURA Aura Biosciences, Inc. | Sale | 1,519 | $5.15 | $7,823 Sale | Form 4 ↗ |
| May 16, 2025 | Anthony S. Gibney See Remarks | AURA Aura Biosciences, Inc. | Buy | 50,000 | $4.90 | $245.0K Buy | Form 4 ↗ |
| Apr 16, 2025 | Amy Elazzouzi Senior Vice President, Finance | AURA Aura Biosciences, Inc. | Sale | 897 | $5.49 | $4,925 Sale | Form 4 ↗ |
| Apr 16, 2025 | Conor Kilroy See Remarks | AURA Aura Biosciences, Inc. | Sale | 7,162 | $5.49 | $39.3K Sale | Form 4 ↗ |
| Feb 18, 2025 | Mark Plavsic Chief Technology Officer | AURA Aura Biosciences, Inc. | Sale | 2,151 | $7.75 | $16.7K Sale | Form 4 ↗ |
| Feb 18, 2025 | Amy Elazzouzi Senior Vice President, Finance | AURA Aura Biosciences, Inc. | Sale | 1,404 | $7.75 | $10.9K Sale | Form 4 ↗ |
| Feb 18, 2025 | Janet Jill Hopkins Chief Medical Officer | AURA Aura Biosciences, Inc. | Sale | 2,534 | $7.75 | $19.6K Sale | Form 4 ↗ |
| Feb 18, 2025 | Pinos Elisabet de los See Remarks, Director | AURA Aura Biosciences, Inc. | Sale | 20,221 | $7.75 | $156.7K Sale | Form 4 ↗ |
| Jan 21, 2025 | Pinos Elisabet de los See Remarks, Director | AURA Aura Biosciences, Inc. | Sale | 15,955 | $7.67 | $122.4K Sale | Form 4 ↗ |
| Jan 21, 2025 | Amy Elazzouzi Vice President, Finance | AURA Aura Biosciences, Inc. | Sale | 1,001 | $7.67 | $7,678 Sale | Form 4 ↗ |
| Nov 18, 2024 | Janet Jill Hopkins Chief Medical Officer | AURA Aura Biosciences, Inc. | Sale | 11,822 | $9.36 | $110.7K Sale | Form 4 ↗ |
| Oct 29, 2024 | Pinos Elisabet de los See Remarks, Director | AURA Aura Biosciences, Inc. | Sale | 9,200 | $10.74 | $98.8K Sale | Form 4 ↗ |
| Oct 29, 2024 | Amy Elazzouzi Vice President, Finance | AURA Aura Biosciences, Inc. | Sale | 553 | $10.74 | $5,939 Sale | Form 4 ↗ |
| Oct 18, 2024 | Julie B. Feder Chief Financial Officer | AURA Aura Biosciences, Inc. | Sale | 25,131 | $12.03 | $302.3K Sale | Form 4 ↗ |
| Oct 18, 2024 | Pinos Elisabet de los See Remarks, Director | AURA Aura Biosciences, Inc. | Sale | 24,992 | $12.04 | $300.9K Sale | Form 4 ↗ |
| Oct 16, 2024 | Mark Plavsic Chief Technology Officer | AURA Aura Biosciences, Inc. | Sale | 7,383 | $9.85 | $72.7K Sale | Form 4 ↗ |
32 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 9:50 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances